T

Theriva Biologics
D

TOVX

0.18240
USD
0.00
(1.45%)
مغلق
حجم التداول
4,026
الربح لكل سهم
-2
العائد الربحي
-
P/E
0
حجم السوق
6,509,555
المقالات

العنوان: Theriva Biologics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.